Dr. Premal H Thaker, M.D., M.S.
Claim this profileWashington University School of Medicine
Expert in Ovarian Cancer
Expert in Endometrial Cancer
35 reported clinical trials
65 drugs studied
About Premal H Thaker, M.D., M.S.
Education:
- Completed a combined BSc/MD program at Villanova University.
- Earned an MD degree from Allegheny University in Philadelphia.
Experience:
- Completed a Residency in OB/GYN at the Hospital of the University of Pennsylvania.
- Undertook a Fellowship in Gynecologic Oncology at M. D. Anderson Cancer Center.
- Served as an Assistant Professor at Washington University in St. Louis since 2006, promoted to Professor in 2018.
- Appointed as the inaugural David & Lynn Mutch Distinguished Professor of Obstetrics and Gynecology at Washington University School of Medicine.
- Director of Gynecologic Oncology Clinical Trials and Clinical Research at Washington University School of Medicine.
- Recognized for outstanding patient care, consistently named to the St. Louis Best Doctor's list since 2013 and Castle Connolly since 2021.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
KRAS positive
NRAS positive
2Endometrial Cancer
Global LeaderStage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Premal H Thaker, M.D., M.S. is currently running
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 37 criteria
Zanzalintinib + Paclitaxel
for Uterine Cancer
The purpose of this study is to determine the recommended Phase 2 dose of zanzalintinib when given in combination with paclitaxel in patients with recurrent high-grade uterine cancer. Other objectives include overall safety and tolerability as well as rates of response.
Recruiting1 award Phase 15 criteria
More about Premal H Thaker, M.D., M.S.
Clinical Trial Related3 years of experience running clinical trials · Led 35 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments Premal H Thaker, M.D., M.S. has experience with
- Paclitaxel
- Carboplatin
- Bevacizumab
- Brachytherapy
- Gemcitabine
- Cisplatin
Breakdown of trials Premal H Thaker, M.D., M.S. has run
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Premal H Thaker, M.D., M.S. specialize in?
Premal H Thaker, M.D., M.S. focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Premal H Thaker, M.D., M.S. currently recruiting for clinical trials?
Yes, Premal H Thaker, M.D., M.S. is currently recruiting for 12 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Premal H Thaker, M.D., M.S. has studied deeply?
Yes, Premal H Thaker, M.D., M.S. has studied treatments such as Paclitaxel, Carboplatin, Bevacizumab.
What is the best way to schedule an appointment with Premal H Thaker, M.D., M.S.?
Apply for one of the trials that Premal H Thaker, M.D., M.S. is conducting.
What is the office address of Premal H Thaker, M.D., M.S.?
The office of Premal H Thaker, M.D., M.S. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.